In a report released on June 25, Pablo de Renteria from Kepler Capital maintained a Buy rating on bioMerieux, with a price target of €85.00. Th...
According to TipRanks, de Renteria is an analyst with an average return of -4.3% and a 41.86% success rate.
bioMerieux has an analyst consensus of Hold, with a price target consensus of €76.70.
The company has a one-year high of €128.30 and a one-year low of €65.60. Currently, bioMerieux has an average volume of 203.5K.
Kepler Capital analyst Pablo de Renteria maintained a Buy rating on DiaSorin S.p.A. on June 25 and set a price target of €76.00.…
In a report released on June 5, Frederic Renard from Kepler Capital maintained a Buy rating on Montea SCA, with a price target…
In a report released on June 5, Thomas Neuhold from Kepler Capital maintained a Buy rating on LEG Immobilien, with a price…
In a report released on June 5, Frederic Renard from Kepler Capital maintained a Hold rating on Care Property Investment, with a…
In a report released on May 15, Alexander Craeymeersch from Kepler Capital maintained a Hold rating on Bekaert SA, with a price…
RBC Capital analyst Richard Chamberlain maintained a Buy rating on B&M European Value Retail SA on June 8 and set a price target…
